+251.5%
MRNA vs VG
-39.3%
+290.8%
-50.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | VG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.4% | -1.8% | -2.2% |
| 7D | +5.5% | +1.7% | +3.8% | +5.5% |
| 30D | +158.7% | +16.0% | +142.7% | +155.6% |
| 3M | +182.1% | +9.7% | +172.4% | +178.7% |
| 6M | +151.8% | +29.6% | +122.2% | +137.0% |
| YTD | +393.6% | +112.0% | +281.5% | +324.6% |
| 1Y | +499.5% | +12.8% | +486.7% | +458.3% |
| All | +251.5% | -39.3% | +290.8% | +226.1% |
Cumulative growth
Daily Returns
Daily percentage return beside VG.
Daily Out/Under-Performance
Portfolio return minus VG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded VG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling